Japanese Case of Enzalutamide-Resistant Prostate Cancer Harboring a SPOP Mutation With Scattered Allelic Imbalance: Response to Platinum-Based Therapy

Keitaro Watanabe; Takeo Kosaka; Eriko Aimono; Hiroshi Hongo; Shuji Mikami; Hiroshi Nishihara; Mototsugu Oya

doi:10.1016/j.clgc.2019.06.005

Japanese Case of Enzalutamide-Resistant Prostate Cancer Harboring a SPOP Mutation With Scattered Allelic Imbalance: Response to Platinum-Based Therapy

Keitaro Watanabe, Takeo Kosaka, Eriko Aimono, Hiroshi Hongo, Shuji Mikami, Hiroshi Nishihara, Mototsugu Oya

研究成果: Article › 査読

本文言語	English
ページ（範囲）	e897-e902
ジャーナル	Clinical Genitourinary Cancer
巻	17
号	5
DOI	https://doi.org/10.1016/j.clgc.2019.06.005
出版ステータス	Published - 2019 10月

ASJC Scopus subject areas

腫瘍学
泌尿器学

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1016/j.clgc.2019.06.005

他のファイルとリンク

引用スタイル

@article{be45f8ad17034046b210682cb88afc7e,

title = "Japanese Case of Enzalutamide-Resistant Prostate Cancer Harboring a SPOP Mutation With Scattered Allelic Imbalance: Response to Platinum-Based Therapy",

keywords = "Enzalutamide-resistant, Neuroendocrine differentiation, Platinum-based therapy, Prostate cancer, SPOP mutation",

author = "Keitaro Watanabe and Takeo Kosaka and Eriko Aimono and Hiroshi Hongo and Shuji Mikami and Hiroshi Nishihara and Mototsugu Oya",

note = "Funding Information: Yoko Suzuki, Emmy Yanagida, and Hiroshi Yamada provided technical assistance. This study was supported in part by Grants-in-Aid for Scientific Research (#17K11158 to T. Kosaka) from the Ministry of Education, Culture, Sports, Science and Technology of Japan , and by a research Grant to T. Kosaka from the Takeda Science Foundation , Japan. ",

year = "2019",

month = oct,

doi = "10.1016/j.clgc.2019.06.005",

language = "English",

volume = "17",

pages = "e897--e902",

journal = "Clinical Genitourinary Cancer",

issn = "1558-7673",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - Japanese Case of Enzalutamide-Resistant Prostate Cancer Harboring a SPOP Mutation With Scattered Allelic Imbalance

T2 - Response to Platinum-Based Therapy

AU - Watanabe, Keitaro

AU - Kosaka, Takeo

AU - Aimono, Eriko

AU - Hongo, Hiroshi

AU - Mikami, Shuji

AU - Nishihara, Hiroshi

AU - Oya, Mototsugu

N1 - Funding Information: Yoko Suzuki, Emmy Yanagida, and Hiroshi Yamada provided technical assistance. This study was supported in part by Grants-in-Aid for Scientific Research (#17K11158 to T. Kosaka) from the Ministry of Education, Culture, Sports, Science and Technology of Japan , and by a research Grant to T. Kosaka from the Takeda Science Foundation , Japan.

PY - 2019/10

Y1 - 2019/10

KW - Enzalutamide-resistant

KW - Neuroendocrine differentiation

KW - Platinum-based therapy

KW - Prostate cancer

KW - SPOP mutation

UR - http://www.scopus.com/inward/record.url?scp=85068445024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068445024&partnerID=8YFLogxK

U2 - 10.1016/j.clgc.2019.06.005

DO - 10.1016/j.clgc.2019.06.005

M3 - Article

C2 - 31296452

AN - SCOPUS:85068445024

SN - 1558-7673

VL - 17

SP - e897-e902

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

IS - 5

ER -